Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression-Reference-Cited by-同舟云学术

Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression

Published:2021-12-17 Issue: Volume: Page:
ISSN:2578-5125
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Wiese Beth M.¹^ORCID,Liktor-Busa Erika¹,Couture Sarah A.¹,Nikas Spyros P.²,Ji Lipin²,Liu Yingpeng²,Makriyannis Alexandros²,Spigelman Igor³,Vanderah Todd W.¹⁴,Largent-Milnes Tally M.¹⁴

Affiliation:

1. Department of Pharmacology, University of Arizona, Tucson, Arizona, USA.

2. Chemistry and Chemical Biology, Bouve College Health Sciences—Center for Drug Discovery, Northeastern University, Boston, Massachusetts, USA.

3. Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, California, USA.

4. Comprehensive Pain and Addiction Center, University of Arizona, Health Sciences, Tucson, Arizona, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Link

https://www.liebertpub.com/doi/pdf/10.1089/can.2021.0090

Reference47 articles.

1. 1. National Academies of Sciences E, Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. The National Academies Press: Washington, DC, 2017.

2. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain

3. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain

4. Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report

5. Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous opiates and behavior: 2022;Peptides;2023-11

2. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review;Behavioural Neurology;2023-10-12

3. The endocannabinoid system and breathing;Frontiers in Neuroscience;2023-04-18

4. Inhaled Δ9-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteers;British Journal of Anaesthesia;2023-04